Hikal's Crop Protection Business Contributes to Steady Q1 FY27 Revenue

Meta Keywords: Hikal Crop Protection, Crop Protection Business, Hikal Q1 FY27

Introduction

Hikal Limited began fiscal year 2027 with a modest improvement in consolidated revenue, supported in part by the continued contribution of its Crop Protection business. For the quarter ended June 30, 2026, Hikal reported consolidated revenue of ₹403 crore, up 5.9% from ₹380 crore in Q1 FY26.

While the company's overall performance improved year on year, the Crop Protection segment continued to operate in a challenging global environment characterized by pricing pressure, customer inventory adjustments and elevated input costs.

Crop Protection Revenue Reaches ₹170 Crore

Hikal's Crop Protection business generated ₹170 crore in revenue during Q1 FY27, compared with ₹178 crore in Q1 FY26 and ₹228 crore in Q4 FY26. The segment accounted for approximately 42% of Hikal's consolidated revenue during the quarter.

Although revenue declined compared with the previous year, the business continued to make a meaningful contribution to Hikal's overall sales base. The sequential decline also reflects the normalization of demand following a stronger Q4 FY26.

Global Crop Protection Market Remains Challenging

Hikal's Crop Protection business continues to face pressure from global industry conditions. Excess production capacity and aggressive pricing, particularly from Chinese suppliers, have affected market prices and customer purchasing patterns.

The company reported that global demand improved gradually during Q1 FY27, but pricing pressure remained significant. Customer inventory adjustments also continued to weigh on demand, particularly within Hikal's CDMO business.

These conditions indicate that the global crop protection market is recovering unevenly, with manufacturers continuing to navigate excess inventories and competitive pricing.

Own Products Show Sequential Improvement

One positive development was the performance of Hikal's Own Products business. The company reported sequential growth in this area, driven primarily by higher domestic volumes.

The share of Own Products in the Crop Protection segment increased to 46% in Q1 FY27, compared with 33% in Q1 FY26 and 26% in Q4 FY26. Meanwhile, CDMO's share declined to 54% from 67% a year earlier.

This shift suggests that domestic demand and Hikal's own product portfolio are becoming increasingly important contributors to the segment.

Profitability Remains Under Pressure

Despite stable revenue contribution, profitability in the Crop Protection segment remained weak. EBIT moved from ₹17 crore in Q1 FY26 to a loss of ₹6 crore in Q1 FY27.

The company attributed the pressure to a significant increase in input costs, including raw materials. Geopolitical developments contributed to higher costs across the supply chain, making it difficult to fully protect margins in a competitive pricing environment.

This highlights the difference between maintaining revenue and maintaining profitability in the current crop protection market.

Overall Q1 FY27 Performance

Hikal's consolidated performance improved compared with the same quarter last year. Revenue increased to ₹403 crore from ₹380 crore, while EBITDA rose 47.4% year on year to ₹37 crore, compared with ₹25 crore in Q1 FY26. EBITDA margin improved from 6.6% to 9.2%.

However, the company still reported a ₹7 crore net loss, compared with a ₹22 crore loss in Q1 FY26. The improvement in EBITDA indicates better operating performance, although depreciation, finance costs and other factors continued to affect the bottom line.

Strategic Diversification Supports the Outlook

Hikal is also working to diversify its business beyond traditional crop protection and pharmaceutical activities. The company has expanded its capabilities in areas such as specialty chemicals and Personal Care.

Its Personal Care business was commercialized in July 2026, with several products expected to contribute revenue during FY27. Hikal also has four Crop Protection CDMO molecules under development, providing potential opportunities for future growth.

The company expects business momentum to strengthen progressively through FY27, supported by improving demand visibility, expanding CDMO opportunities and continued operational improvements.

Outlook for Hikal's Crop Protection Business

The near-term outlook remains mixed. Global crop protection demand is showing gradual improvement, but pricing pressure and excess capacity continue to constrain profitability.

For Hikal, stronger domestic volumes, growth in its Own Products portfolio and the development of new CDMO molecules could provide opportunities for future expansion. At the same time, controlling raw-material costs and improving capacity utilization will remain critical to restoring segment margins.

Conclusion

Hikal's Crop Protection business remains an important contributor to the company's revenue base, generating ₹170 crore in Q1 FY27 and accounting for 42% of consolidated revenue. Although segment revenue declined year on year and EBIT moved into negative territory, improving domestic volumes and a greater contribution from Own Products provide some positive signals.

As the global crop protection market gradually moves toward recovery, Hikal's ability to manage pricing pressure, control input costs and expand its differentiated product portfolio will be key to improving profitability during FY27.